Armata Pharmaceuticals (ARMP) Intangibles (2013 - 2026)

Armata Pharmaceuticals has disclosed Intangibles across 14 years of filings, most recently posting $10.3 million for Q1 2026.

• Intangibles for Q1 2026 came in at $10.3 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.3 million (changed 0.0% YoY), and the FY2025 annual result was $10.3 million, changed 0.0% from the prior year.
• Intangibles came in at $10.3 million for Q1 2026 at Armata Pharmaceuticals, roughly flat from $10.3 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $10.3 million in Q1 2022 to a low of $10.3 million in Q1 2022.
• The 5-year median for Intangibles is $10.3 million (2022), against an average of $10.3 million.
• Peak annual rise in Intangibles reached 0.0% in 2022, while the deepest fall reached 0.0% in 2022.
• Armata Pharmaceuticals' Intangibles stood at $10.3 million in 2022, then changed by 0.0% to $10.3 million in 2023, then changed by 0.0% to $10.3 million in 2024, then changed by 0.0% to $10.3 million in 2025, then changed by 0.0% to $10.3 million in 2026.
• The last three Intangibles figures came in at $10.3 million (Q1 2026), $10.3 million (Q4 2025), and $10.3 million (Q3 2025), per Business Quant data.